Prospective Swiss cohort study of living-kidney donors: study protocol
نویسندگان
چکیده
منابع مشابه
Prospective Swiss cohort study of living-kidney donors: study protocol
Background Offering living kidney donation raised the concern that donors are exposed to unknown risks. All Swiss transplant centres therefore decided to start a prospective cohort study of living kidney donors in Switzerland. This paper describes the rationale for and implementation of this cohort study. Methods/design All kidney donors in Switzerland are registered and examined before donati...
متن کاملA study of renal outcomes in obese living kidney donors.
BACKGROUND Little is known about the long-term outcomes of obese living kidney donors (OLKDs). We undertook this study to describe renal outcomes of OLKDs several years after donation. METHODS We invited 101 OLKDs for follow-up health evaluation. RESULTS Thirty-six subjects (35.6%) completed evaluation at 6.8±1.5 years postdonation. The mean estimated glomerular filtration rate (eGFR) using...
متن کاملEconomic Consequences Incurred by Living Kidney Donors: A Canadian Multi-Center Prospective Study
Some living kidney donors incur economic consequences as a result of donation; however, these costs are poorly quantified. We developed a framework to comprehensively assess economic consequences from the donor perspective including out-of-pocket cost, lost wages and home productivity loss. We prospectively enrolled 100 living kidney donors from seven Canadian centers between 2004 and 2008 and ...
متن کاملAcute and long term mineral metabolism adaptation in living kidney donors: a prospective study.
BACKGROUND Living kidney donors (LKDs) experience an abrupt decline in glomerular filtration rate (GFR). Mineral metabolism adaptations in early CKD are still debated and not well studied in LKDs. We prospectively studied acute and long term mineral metabolism adaptation of LKDs. METHODS From May 2010 to December 2012, we included 27 adult LKDs. Their mineral parameters and renal function wer...
متن کاملRilpivirine use in the Swiss HIV cohort study: a prospective cohort study
BACKGROUND Rilpivirine is safe and effective in HIV-naïve patients with low baseline HIV-RNA or in switch strategy. It offers the advantages of few drug-drug interactions and a favourable toxicity profile. We aimed to determine the reasons for prescribing the rilpivirine (RPV)/tenofovir disoproxil (TDF)/emtricitabine (FTC) co-formulation within the Swiss HIV Cohort Study and to assess its effec...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ Open
سال: 2011
ISSN: 2044-6055
DOI: 10.1136/bmjopen-2011-000202